Mid-Day Breakouts Report - Friday, November 16th, 2012

<<<Previous Mid Day Report	Next Mid Day Report >>>
<<<Previous After Market Report	Next After Market Report >>>

You are not logged in.
This means you CAN ONLY VIEW reports that were published prior to Tuesday, February 20, 2024.
You MUST UPGRADE YOUR MEMBERSHIP if you want to see any current reports.

MIDDAY BREAKOUTS REPORT - FRIDAY, NOVEMBER 16TH, 2012
Previous Mid Day Report Next Mid Day Report >>>

DOW 12581.84 39.46 (0.31%) | NASDAQ 2855.85 18.91 (0.67%) | S&P 500 1357.93 4.6 (0.34%)

Time of Screening : 11/16/2012 12:00:24 PM Report Released : 11/16/2012 12:49:26 PM
Price is: Above 52W High and Less Than 52W High but within 15% of the 52 Week High
Volume Is: At least 75% of 50 Day Average at the time of the screening.
More details about this report...

To View Current Notes and Data on currently Featured Stocks go to the latest
Featured Stocks Page

Symbol/Exchange Company Name Industry Group	PRICE	CHANGE (%Change)	Day High	Volume (% DAV) (50 DAV)	52 Wk Hi % From Hi	Date Featured	Price Featured	Pivot Point
Symbol/Exchange Company Name Industry Group	PRICE	CHANGE (%Change)	Day High	Volume (% DAV) (50 DAV)	52 Wk Hi % From Hi	Date Featured	Price Featured	Max Buy
CMCSA - NASDAQ Comcast Corp Cl A	$35.38	+0.24 0.68%	$35.39	10,424,496 81.83% of 50 DAV 50 DAV is 12,738,600	$37.96 -6.80%	6/11/2012	$29.94	PP = $30.98 MB = $32.53
Most Recent Note - 11/16/2012 12:06:22 PM G - Losses this week violated its 50 DMA line raising concerns and triggering a technical sell signal. A rebound above that short-term average is needed for its outlook improve. Reported earnings +39% on +15% sales revenues for the Sep '12 quarter, a reassuring follow-up to the previously noted sub par quarter. >>> The latest Featured Stock Update with an annotated graph appeared on 10/24/2012. Click here.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
GPX - NYSE G P Strategies Corp	$20.16	-0.44 -2.14%	$20.66	61,060 104.91% of 50 DAV 50 DAV is 58,200	$21.44 -5.97%	10/8/2012	$20.00	PP = $20.77 MB = $21.81
Most Recent Note - 11/16/2012 12:16:34 PM G - Hovering near its 52-week high today. Earnings +0% on +12% sales revenues for the Sep '12 quarter, below the +25% minimum earnings guideline (C criteria) raised fundamental concerns. See the latest FSU analysis for more details and a new annotated graph. >>> The latest Featured Stock Update with an annotated graph appeared on 11/15/2012. Click here.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M

Symbol - Exchange - Industry Group Company Name	Last	Chg	Day High	52 WK Hi	% From Hi	Volume % DAV	DAV
BLL - NYSE - CONSUMER NON-DURABLES - Packaging & Containers Ball Corp	$42.95	-0.29 -0.67%	$43.31	$44.33	-3.11%	602,171 80.21%	750,700
Most Recent Note for BLL - 11/16/2012 12:03:00 PM Consolidating near its 52-week high. Quarterly and annual earnings (C and A criteria) history has been below the guidelines of the fact-based investment system.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
CHS - NYSE - RETAIL - Apparel Stores Chicos Fas Inc	$17.71	+0.09 0.51%	$18.08	$19.76	-10.37%	1,704,500 83.42%	2,043,200
Most Recent Note for CHS - 11/16/2012 12:04:54 PM Consolidating below its 50 DMA line after recently encountering distributional pressure and stubborn resistance near the $19 area. The 11/14/12 mid-day report noted - "Its annual earnings (A criteria) history has been improving since a drastic downturn FY '07-09 while earnings increases have been at or near the +25% minimum guideline (C criteria) in the 3 most recent quarterly comparisons through Jul '12. Due to report earnings on Tuesday November 20, 2012. On 3/8/2006 this company hailing from the Retail - Clothing Shoe industry group was dropped from the Featured Stocks list and it subsequently fell -95.6% before rebounding. Prior notes acknowledged its impressive rebound from its November 2008 low of $1.72. Chicos Fas Inc rose +155% in the 15 month period following its appearance long ago in the December 2003 issue of CANSLIM.net News."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
CYBX - NASDAQ - HEALTH SERVICES - Medical Appliances & Equipment Cyberonics Inc	$50.51	+3.91 8.39%	$52.10	$54.00	-6.46%	457,511 186.43%	245,400
Most Recent Note for CYBX - 11/16/2012 12:10:04 PM Gapped up today, rallying for a considerable gain with a burst of heavy volume as it rebounds above its 50 DMA line toward its 52-week high. Reported earnings +38% on +17% sales revenues for the Oct '12 quarter, marking 5 consecutive quarterly earnings comparisons above the +25% guideline (meeting C criteria). The previously noted dip in FY '11 earnings (A criteria) is why fundamental concerns remain with respect to the fact-based investment system's guidelines.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
FL - NYSE - RETAIL - Apparel Stores Foot Locker Inc	$33.00	+1.15 3.61%	$34.06	$37.65	-12.35%	3,409,468 180.96%	1,884,100
Most Recent Note for FL - 11/16/2012 12:12:35 PM Gapped up today, rallying from support at its 200 DMA line. Reported earnings +47% on +9% sales revenues for the quarter ended Oct 31, 2012 versus the year ago period. Last noted in the 8/17/12 mid-day report - "Quarterly results showed strong earnings increases but sales revenues growth has been sub par and its annual earnings (A criteria) history is not a good match with the investment system's guidelines."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
GPS - NYSE - RETAIL - Apparel Stores Gap Inc Del	$33.52	+0.26 0.78%	$34.73	$37.85	-11.44%	4,232,342 81.55%	5,189,700
Most Recent Note for GPS - 11/16/2012 12:15:28 PM Reported earnings +66% on +8% sales revenues for the Oct '12 quarter, a 2nd consecutive quarter with earnings above the +25% minimum guideline (C criteria). It slumped below its 50 DMA line from new highs hit since last noted in the 9/18/12 mid-day report - "Quarterly and annual earnings history (C and A criteria) is not a match with the investment system's guidelines."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
HVT - NYSE - RETAIL - Home Furnishing Stores Haverty Furniture Inc	$15.24	-0.32 -2.06%	$15.43	$15.69	-2.87%	78,897 114.84%	68,700
Most Recent Note for HVT - 11/16/2012 12:18:21 PM Touched a new 52-week high on the prior session, rallying from support at its 50 DMA line with another volume-driven gain. Prior mid-day reports noted - "Sales and earnings history remains below guidelines of the fact-based investment system."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
MAIN - NYSE - LEISURE - Restaurants Main Street Capital Corp	$28.97	+1.32 4.77%	$28.98	$30.98	-6.49%	323,171 110.64%	292,100
Most Recent Note for MAIN - 11/16/2012 12:19:34 PM Rebounding toward its 50 DMA line after violating it on 11/14/12 with a damaging volume-driven loss. Reported earnings +11% on +34% sales revenues for the Sep '12 quarter, below the +25% minimum earnings guideline (C criteria) for a 2nd consecutive quarter. Retreated to its 200 DMA line before finding support after noted in the 5/04/12 mid-day report - "It completed Public Offerings on 3/22/11 and 10/19/11. Quarterly comparisons have shown strong sales revenues and earnings increases satisfying the C criteria. A downturn in FY '09 earnings is a flaw concerning the A criteria.'"
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
MYL - NASDAQ - DRUGS - Drugs - Generic Mylan Inc	$25.79	+0.29 1.14%	$25.92	$26.55	-2.86%	3,269,491 75.46%	4,332,500
Most Recent Note for MYL - 11/16/2012 12:21:03 PM Hovering near its 52-week high today, holding its ground following a recent spurt of volume-driven gains. Prior mid-day reports noted - "Reported earnings +51%* on +15% sales revenues for the Sep '12 quarter. Quarterly results were below the+25% minimum earnings increase for the prior 3 quarters."*
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
NVO - NYSE - DRUGS - Drug Manufacturers - Other Novo Nordisk A/S Adr	$153.26	+0.96 0.63%	$153.78	$170.27	-9.99%	424,800 89.60%	474,100
Most Recent Note for NVO - 11/16/2012 12:26:38 PM Consolidating after considerable volume-driven losses led to an abrupt retreat from all-time highs to its 200 DMA line which acted as support last week. Reported earnings +34% on +15% sales revenues for the Sep '12 quarter. The 4 prior quarterly comparisons had earnings increases below the +25% guideline (not meeting the C criteria). It has earned high ranks after demonstrating strong steady annual earnings (A criteria) growth. This Denmark-based Medical - Ethical Drug firm also has seen the number of top-rated funds owning its shares rise from 193 in Dec '11 to 221 in Sep '12, a reassuring sign concerning the I criteria.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
OABC - NASDAQ - BANKING - Regional - Southwest Banks Omniamerican Bancorp	$22.50	-0.01 -0.04%	$22.58	$23.20	-3.02%	32,826 131.83%	24,900
Most Recent Note for OABC - 11/16/2012 12:28:24 PM Consolidating near its 50 DMA line which may act as resistance, meanwhile trading only -3% off its 52-week high today. Recent mid-day reports repeatedly noted - "No resistance remains due to overhead supply. Rebounded above its 50 DMA line promptly after dipping below that important short-term average in August, however gains in recent weeks have lacked great volume conviction. Recent quarters showed better earnings versus the year earlier, however unimpressive sales revenues growth suggests no great demand for new (N criteria) products or services."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
PRXL - NASDAQ - DIVERSIFIED SERVICES - Research Services Parexel Intl Corp	$31.39	-0.09 -0.29%	$31.80	$32.47	-3.33%	321,030 80.14%	400,600
Most Recent Note for PRXL - 11/16/2012 12:32:25 PM Perched just -2.5% off its 52-week high today. Found support near its 50 DMA line in recent weeks since last noted in the 10/31/12 mid-day report - "Reported earnings +45% on +28% sales for the Sep '12 quarter. Prior growth has not been strong and steady. Survived but failed to impress since dropped from the Featured Stocks list on 10/02/08. Today its fundamentals are below the investment system guidelines. Members may view its Company Profile page under the 'Featured Articles and Daily Graphs' tab when the last FSU article under the headline, 'Pulling Parachute Early Can Spare Yourself Some Pain', gives a clear look back at its prior breakdown - an example why losses should always be limited at 7-8%."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
REGN - NASDAQ - DRUGS - Biotechnology Regeneron Pharmaceutical	$154.99	+12.52 8.79%	$155.59	$166.39	-6.85%	676,103 92.46%	731,200
Most Recent Note for REGN - 11/16/2012 12:34:46 PM Rallying back above its 50 DMA line today, trading -4.6% off its 52-week high. No overhead supply remains to act as resistance. Reported greatly improved sales revenues and earnings versus year-ago losses for the Mar, Jun, and Sep '12 quarters. Encountered distributional pressure since last noted in the 10/25/12 mid-day report - "Earnings history is not a match with the investment system's fundamental guidelines."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
ROP - NYSE - MANUFACTURING - Diversified Machinery Roper Industries Inc	$108.34	+0.65 0.60%	$108.65	$111.75	-3.05%	440,026 103.78%	424,000
Most Recent Note for ROP - 11/16/2012 12:36:00 PM Consolidating near its 50 DMA line and only -3.1% off its 52-week high. Reported earnings +11% on +5% sales revenues for the quarter ended Sep 30, 2012 versus the year ago period. That marked 4 consecutive quarterly comparisons with earnings increases below the +25% minimum guideline (missing the C criteria). Its annual earnings (A criteria) history is below the fact-based system's guidelines.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
SIRO - NASDAQ - HEALTH SERVICES - Medical Instruments & Supplies Sirona Dental Systems	$61.60	+4.53 7.94%	$63.86	$63.86	-3.54%	918,997 234.50%	391,900
Most Recent Note for SIRO - 11/16/2012 12:39:12 PM Gapped up today for a considerable gain and a new 52-week high. It found support at its 50 DMA line again since last noted in the 10/18/12 mid-day report - "Quarterly comparisons have shown sub par sales revenues and earnings increases. It survived but failed to impress since last noted when dropped from the Featured Stocks list on 5/20/10."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
VRTS - NASDAQ - FINANCIAL SERVICES - Asset Management Virtus Investment Ptnrs	$100.06	-0.48 -0.48%	$100.85	$105.30	-4.98%	158,145 463.77%	34,100
Most Recent Note for VRTS - 11/16/2012 12:40:08 PM Holding its ground today near its 52-week high following a recent spurt of gains, extended from any sound base. Prior mid-day reports noted - "Recent quarterly comparisons shown greatly improved earnings and sales revenues. Prior earnings history is below the fact-based system's guidelines."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
VRX - NYSE - DRUGS - Drug Manufacturers - Other Valeant Pharmaceuticals	$55.05	+1.73 3.24%	$55.05	$61.11	-9.92%	1,045,709 79.96%	1,307,800
Most Recent Note for VRX - 11/16/2012 12:42:33 PM Consolidating below its 50 DMA line after encountering recent distributional pressure. Last noted in the 9/14/12 mid-day report - "Quarterly earnings increases (C criteria) have been strong and well above the +25% guideline. A downturn in FY '07 and '08 earnings (A criteria) has been followed by a strong earnings rebound in recent years."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
WDR - NYSE - FINANCIAL SERVICES - Investment Brokerage - Regiona Waddell & Reed Finl Cl A	$32.09	-0.79 -2.40%	$33.18	$34.57	-7.17%	630,087 94.54%	666,500
Most Recent Note for WDR - 11/16/2012 12:45:10 PM Annual earnings (A criteria) history included a downturn in FY '08 and '09. Reported earnings +33% on +5% sales revenues for the Sep '12 quarter but prior quarterly comparisons were below the +25% minimum earnings guideline (C criteria).
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
WX - NYSE - DRUGS - Drug Manufacturers - Other Wuxi Pharmatech Inc Ads	$15.69	+0.09 0.58%	$15.88	$15.88	-1.20%	219,553 75.50%	290,800
Most Recent Note for WX - 11/16/2012 12:46:14 PM This Chinese Medical/Dental Services firm rallied to another new 52-week high with today's gain. The 11/14/12 mid-day report noted - "It faces additional resistance due to overhead supply up through the $19-20 area. Earnings history is not a match with the fact-based investment system's guidelines, with the 3 latest quarterly comparisons through Sep '12 showing earnings increases below the +25% guideline (C criteria)."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
WYN - NYSE - LEISURE - Resorts & Casinos Wyndham Worldwide Corp	$48.60	-0.38 -0.78%	$49.44	$55.41	-12.29%	1,043,332 89.43%	1,166,600
Most Recent Note for WYN - 11/16/2012 12:49:05 PM Edging below its 200 DMA line this week and -11.6% off its 52-week high today. Reported earnings +20% on +4% sales revenues for the Sep '12 quarter. Last noted in the 8/22/12 mid-day report - "Sales revenues growth has been sub par and its annual earnings (A criteria) history included a downturn in FY '09. Due to fundamental concerns it is not a good match with the winning models of the fact-based investment system."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M

THESE ARE NOT BUY RECOMMENDATIONS! Comments contained in the body of this report are technical opinions only. The material herein has been obtained from sources believed to be reliable and accurate, however, its accuracy and completeness cannot be guaranteed. We are not an investment advisor, hence it does not endorse or recommend any securities or other investments. Any recommendation contained in this report may not be suitable for all investors and it is not to be deemed an offer or solicitation on our part with respect to the purchase or sale of any securities. All trademarks, service marks and trade names appearing in this report are the property of their respective owners, and are likewise used for identification purposes only.

This report is a service available only to active Paid Premium Members. You may opt-out of receiving report notifications at any time. Questions or comments may be submitted by writing to FactBasedInvesting.com c/o Premium Member Services 665 S.E. 10 Street, Suite 201 Deerfield Beach, FL 33441-5634 or by calling 954-785-1121.

We appreciate any feedback members may wish to send via the inquiry form here.